The firm presently has a $30.00 price target on the medical device company's stock. Zacks Investment Research's price objective would suggest a potential upside of 21.75% from the company's previous close.

The brokerage currently has a $27.00 price target on the medical device company's stock. Zacks Investment Research's target price would suggest a potential upside of 13.66% from the company's current price.